Phibro Animal Health Corporation PAHC
37.61 USD -1.13 (-2.92%)
Nov 3, 2026, 3:23 PM EST
37.36 Day range 39.53
28.25 52-week range 60.08
- YTD
- +0.67%
- 1 year
- -13.28%
News
businesswire.com Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 4, 2026, after the market closes. Phibro…
zacks.com Will Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report? Phibro (PAHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zacks.com PAHC or SYK: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with…
zacks.com PAHC vs. HAE: Which Stock Is the Better Value Option? Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the…
defenseworld.net Head-To-Head Survey: Tvardi Therapeutics (NASDAQ:TVRD) versus Phibro Animal Health (NASDAQ:PAHC) Tvardi Therapeutics (NASDAQ: TVRD - Get Free Report) and Phibro Animal Health (NASDAQ: PAHC - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will…
zacks.com Best Momentum Stocks to Buy for September 21st SEI, SDRL and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 21st, 2026.
zacks.com PAHC vs. HAE: Which Stock Should Value Investors Buy Now? Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors…
defenseworld.net Phibro Animal Health Corporation $PAHC Shares Acquired by Engineers Gate Manager LP Engineers Gate Manager LP boosted its position in Phibro Animal Health Corporation (NASDAQ: PAHC) by 112.8% during the undefined quarter, according to the company in its most recent filing with the…
zacks.com 4 Stocks With Strong Interest Coverage to Buy as Yields Rise DiamondRock Hospitality, Vertiv, Mueller Water Products and Phibro Animal Health stand out for strong interest coverage as Treasury yields rise.
zacks.com Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
businesswire.com Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. President & Chief…
zacks.com PAHC or LMAT: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks is more…
seekingalpha.com Phibro Animal Health: Zoetis Integrated And Better Cash Flow Ahead Phibro Animal Health's Zoetis MFA acquisition has created a larger animal health platform with stronger earnings and broader manufacturing reach. Vaccines, nutritional specialties, and…
defenseworld.net Phibro Animal Health Q4 Earnings Call Highlights Phibro Animal Health (NASDAQ: PAHC) reported record fiscal 2026 sales and a sharp increase in adjusted EBITDA, supported by growth in its Animal Health and Mineral Nutrition businesses, the…
seekingalpha.com Phibro Animal Health Corporation (PAHC) Q4 2026 Earnings Call Transcript Phibro Animal Health Corporation (PAHC) Q4 2026 Earnings Call Transcript
marketbeat.com Phibro Animal Health Q4 Earnings Call Highlights Phibro Animal Health NASDAQ: PAHC reported record fiscal 2026 sales and a sharp increase in adjusted EBITDA, supported by growth in its Animal Health and Mineral Nutrition businesses, the integration…
benzinga.com Phibro Animal Health Q4 2026 Earnings Call: Complete Transcript Phibro Animal Health (NASDAQ:PAHC) held its fourth-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs.…
zacks.com Phibro (PAHC) Reports Q4 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street…
zacks.com Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates Phibro Animal Health (PAHC) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.57 per share a year ago.
benzinga.com Phibro Animal Health Corp To Close Chicago Heights Facility In Summer 2027, Affecting About 100 Employees MFA SITE CLOSUREThrough the MFA acquisition in 2024, Phibro added several manufacturing facilities. Since then, we have conducted a comprehensive review of our manufacturing network to ensure our…
benzinga.com Phibro Animal Health Sees FY2027 Adj EPS $3.41-$3.59 vs $3.34 Est; Sees Sales $1.550B-$1.600B vs $1.548B Est Phibro Animal Health (NASDAQ:PAHC) is looking for FY2027 Adj EPS of $3.41-$3.59 vs $3.34 analyst estimate. sees sales of $1.550 billion-$1.600 billion vs $1.548 billion analyst estimate.
businesswire.com Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30,…
zacks.com Phibro (PAHC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates Besides Wall Street's top-and-bottom-line estimates for Phibro (PAHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the…
benzinga.com Phibro Animal Health Appoints Daniel (Dani) Bendheim As CEO And President Effective July 1, 2026 https://www.sec.gov/ix?doc=/Archives/edgar/data/0001069899/000110465926078323/tm2619111d1_8k.htm- benzinga.com Citigroup Maintains Neutral on Phibro Animal Health, Lowers Price Target to $44 Citigroup analyst Daniel Grosslight maintains Phibro Animal Health (NASDAQ:PAHC) with a Neutral and lowers the price target from $62 to $44.
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.93-$3.10 to $2.98-$3.10 vs $3.03 Est; Raises FY2026 Sales Guidance from $1.45B-$1.50B to $1.46B-$1.50B vs $1.488B Est FISCAL YEAR 2026 FINANCIAL GUIDANCEOur updated fiscal year 2026 financial guidance is as shown below. Year-over-year percentages are calculated using the midpoint of the guidance ranges.Net sales of…- benzinga.com Phibro Animal Health Corporation Announces Expected Implementation Of New Regulatory Framework Governing The Use Of Certain Antimicrobials In Brazil The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27, 2026, prohibiting the importation, manufacture, marketing and use of performance enhancing feed…
- benzinga.com Citigroup Initiates Coverage On Phibro Animal Health with Neutral Rating, Announces Price Target of $62 Citigroup analyst Daniel Grosslight initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Neutral rating and announces Price Target of $62.
benzinga.com Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday 
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session 
benzinga.com Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket 
benzinga.com Phibro Animal Health Raises FY2026 GAAP EPS Guidance from $1.83-$2.08 to $2.08-$2.32 vs $1.99 Est Phibro Animal Health (NASDAQ:PAHC) raises FY2026 GAAP EPS guidance from $1.83-$2.08 to $2.08-$2.32 vs $1.99 analyst estimate..- benzinga.com Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.64-$2.81 to $2.93-$3.10 vs $2.74 Est; Raises FY2026 Sales Guidance from $1.430B-$1.480B to $1.450B-$1.500B vs $1.466B Est Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.64-$2.81 to $2.93-$3.10 vs $2.74 analyst estimate. Raises FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.450…
benzinga.com Phibro Animal Health Earnings Review: Q2 Summary - benzinga.com Phibro Animal Health Q2 Adj. EPS $0.87 Beats $0.67 Estimate, Sales $373.900M Beat $355.637M Estimate Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.67 by 29.85 percent. This is a 58.18 percent increase over earnings…
- benzinga.com Earnings Scheduled For February 4, 2026
benzinga.com Earnings Preview For Phibro Animal Health 
benzinga.com JP Morgan Maintains Overweight on Phibro Animal Health, Raises Price Target to $50 JP Morgan analyst Ekaterina Knyazkova maintains Phibro Animal Health (NASDAQ:PAHC) with a Overweight and raises the price target from $45 to $50.- benzinga.com Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.52-$2.70 to $2.64-$2.81 vs $2.63 Est; Affirms FY2026 Sales Guidance of $1.430B-$1.480B vs $1.459B Est Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.52-$2.70 to $2.64-$2.81 vs $2.63 analyst estimate. Affirms FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.430…
benzinga.com Phibro Animal Health Q1 Adj. EPS $0.73 Beats $0.62 Estimate, Sales $363.900M Beat $346.957M Estimate Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.62 by 17.17 percent. This is a 108.57 percent increase over earnings…
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com A Preview Of Phibro Animal Health's Earnings - benzinga.com Phibro Animal Health To Develop, Commercialize Lighthouse Pharma's Proprietary Compound For Canine Periodontal Care Under Signed Licensing Agreement TEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ:PAHC), a global leader in animal health and nutrition, today announced it has entered into a licensing agreement with…
benzinga.com B of A Securities Maintains Underperform on Phibro Animal Health, Raises Price Target to $27 B of A Securities analyst Derik De Bruin maintains Phibro Animal Health (NASDAQ:PAHC) with a Underperform and raises the price target from $19 to $27.- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Phibro Animal Health, Pure Storage, Snowflake, Build-A-Bear Workshop And Other Big Stocks Moving Higher On Thursday 
benzinga.com Stock Market Today: Nvidia Drags Down Nasdaq Futures, Dow Trades Higher—Dollar General, Dell, Best Buy In Focus (UPDATED) U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largely mixed.- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket